Semaglutide

Anti-diabetic and anti-obesity medication

Semaglutide ▸ Facts ▸ Comments ▸ News ▸ Videos

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012.

0 shares	Share Tweet Save Post Send

You Might Like

Ozempic and Saxenda under investigation in EU Two drugs used as diabetes and weight-loss treatments are being investigated after some patients reported having suicidal thoughts. Sky News - Published on July 11, 2023
Obesity patients made to feel like 'second-class citizens' as demand for Ozempic soars People battling chronic obesity are facing stigmatisation as they try to obtain the much-vaunted drug Ozempic amid shortages in Ireland and elsewhere, according to doctors. Sky News - Published on June 23, 2023
'RHOBH' Kyle Richards Denies Using Ozempic for Weight Loss, Blames Anxiety Kyle Richards is setting the record straight about how she obtained her toned body ... saying she's never used the diabetes drug Ozempic, instead, she's putting the work in herself. The "Real.. TMZ.com - Published on May 23, 2023

Next wave of weight loss jabs could be coming - this time without the nausea Weight loss jabs such as Ozempic and Wegovy have been hailed as the future of obesity treatment - but some users are debilitated by nausea and regain the lost pounds as soon as they stop injections. Sky News - Published on March 29, 2023